Nuance Biotech
An innovative biotech company dedicated to the three major areas of pharmaceutical business operations in the Chinese market.
Launch date
Employees
Market cap
-
Enterprise valuation
€429—644m (Dealroom.co estimates Dec 2020.)
Shanghai Shanghai (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$8.0m | Series A | ||
$20.0m | Series B | ||
N/A | $2.0m | Series C | |
$118m | Series D | ||
Total Funding | €135m |
Related Content
Recent News about Nuance Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Nuance Biotech
EditACQUISITION by Nuance Biotech Jan 2022
ACQUISITION by Nuance Biotech Jan 2022